Loading...

GENOVA, Inc.

9341.TJPX
Healthcare
Medical - Healthcare Information Services
¥571.00
¥1.00(0.18%)
Japanese Market opens in 12h 52m

GENOVA, Inc. Fundamental Analysis

GENOVA, Inc. (9341.T) shows weak financial fundamentals with a PE ratio of 35.35, profit margin of 2.38%, and ROE of 4.16%. The company generates $11.6B in annual revenue with strong year-over-year growth of 15.59%.

Key Strengths

Cash Position54.61%
PEG Ratio-0.44
Current Ratio3.73

Areas of Concern

ROE4.16%
Operating Margin3.46%
We analyze 9341.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 50.5/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
50.5/100

We analyze 9341.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

9341.T struggles to generate sufficient returns from assets.

ROA > 10%
2.69%

Valuation Score

Moderate

9341.T shows balanced valuation metrics.

PE < 25
35.35
PEG Ratio < 2
-0.44

Growth Score

Moderate

9341.T shows steady but slowing expansion.

Revenue Growth > 5%
15.59%
EPS Growth > 10%
-80.07%

Financial Health Score

Excellent

9341.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.11
Current Ratio > 1
3.73

Profitability Score

Weak

9341.T struggles to sustain strong margins.

ROE > 15%
4.16%
Net Margin ≥ 15%
2.38%
Positive Free Cash Flow
No

Key Financial Metrics

Is 9341.T Expensive or Cheap?

P/E Ratio

9341.T trades at 35.35 times earnings. This suggests a premium valuation.

35.35

PEG Ratio

When adjusting for growth, 9341.T's PEG of -0.44 indicates potential undervaluation.

-0.44

Price to Book

The market values GENOVA, Inc. at 1.41 times its book value. This may indicate undervaluation.

1.41

EV/EBITDA

Enterprise value stands at 26.33 times EBITDA. This signals the market has high growth expectations.

26.33

How Well Does 9341.T Make Money?

Net Profit Margin

For every $100 in sales, GENOVA, Inc. keeps $2.38 as profit after all expenses.

2.38%

Operating Margin

Core operations generate 3.46 in profit for every $100 in revenue, before interest and taxes.

3.46%

ROE

Management delivers $4.16 in profit for every $100 of shareholder equity.

4.16%

ROA

GENOVA, Inc. generates $2.69 in profit for every $100 in assets, demonstrating efficient asset deployment.

2.69%

Following the Money - Real Cash Generation

Operating Cash Flow

GENOVA, Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

GENOVA, Inc. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

9341.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

35.35

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.44

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.41

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.84

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.11

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.73

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.04

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How 9341.T Stacks Against Its Sector Peers

Metric9341.T ValueSector AveragePerformance
P/E Ratio35.3528.92 Worse (Expensive)
ROE4.16%747.00% Weak
Net Margin2.38%-49468.00% (disorted) Weak
Debt/Equity0.110.40 Strong (Low Leverage)
Current Ratio3.734.13 Strong Liquidity
ROA2.69%-19478.00% (disorted) Weak

9341.T outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews GENOVA, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

199.53%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-57.29%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-95.02%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ